Thygesen, Helene H.
University of Leeds
4 papers on CoChatORCID 0000-0003-0453-5144
Most cited papers
- Verified
Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms.
't Hoen, P. A. C., Ariyurek, Y., Thygesen, H. H., Vreugdenhil, E., Vossen, R. H. A. M., de Menezes, R. X., Boer, J. M., van Ommen, G.-J. B., & den Dunnen, J. T. (2008) · Nucleic Acids Research
Gene expression and cancer classificationGenomics and Phylogenetic Studies
Cited by 742
- Verified
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer
Westbrook, J. A., Wood, S. L., Cairns, D. A., McMahon, K., Gahlaut, R., Thygesen, H., Shires, M., Roberts, S., Marshall, H., Oliva, M. R., et al. (2019) · The Journal of Pathology
Bone health and treatmentsBreast Cancer Treatment Studies
Cited by 47
- Verified
The potential utility of geminin as a predictive biomarker in breast cancer.
Sundara Rajan, S., Hanby, A. M., Horgan, K., Thygesen, H. H., & Speirs, V. (2014) · Breast Cancer Research and Treatment
Breast Cancer Treatment StudiesBreast Lesions and Carcinomas
Cited by 21
- Verified
Investigation of the robustness of two models for assessing synergy in pre‐clinical drug combination studies
Whitehead, A., Su, T., Thygesen, H., Sperrin, M., & Harbron, C. (2013) · Pharmaceutical Statistics
Statistical Methods in Clinical TrialsOptimal Experimental Design Methods
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free